Materials and methods
Stavanger University Hospital serves a population of about 300,000 in the southern part of Rogaland County, Norway. Data on the distribution of age and gender of the living epilepsy patients (N = 2480) at the end of the study period were obtained from the database of Stavanger University Hospital and the corresponding data for the general population of Rogaland per January 1 2005 (N = 393,104) from Statistics Norway (www.ssb.no).
The direct and the contributing causes of death (COD) of all incident and prevalent cases that were registered with a diagnosis of epilepsy at Stavanger University Hospital in the ten-year period 01.08.1995-31.07.2005 and who had died during the same period (N = 268) were obtained retrospectively from the Norwegian Cause of Death Registry. Two cases of SUDEP (one definite and one possible) that were registered with a diagnosis of epilepsy before the study period, but died during the same period, were also included. After review of the medical records to confirm the epilepsy diagnosis, four cases were excluded. This resulted in a total of 266 deceased patients with epilepsy. The SUDEP cases were classified as definite, probable or possible. 7, 8 The results of the study were based on the direct causes of death. From Statistics Norway (www.ssb.no), we also obtained data on the number of deaths, and also age and gender, among the general population in the diagnostic categories ''cerebrovascular'' (ICD-9 430-438; ICD-10 I 60-69), ''heart disease'' (ICD- Pearson chi-square and Fisher Exact tests were used to compare the proportionate mortality ratio between deceased patients with epilepsy and the deceased from the general population.
The study was approved by the Regional Committee of Medical Research Ethics.
Results
The COD of the 266 deceased patients with epilepsy are summarized in Table 1 and compared with those of 29,332 persons in the general population.
Deaths from brain tumor were excluded from the analysis. Of those remaining, 25.5% (56/220) of the deaths in patients with epilepsy and 26.4% of the deaths in the general population were caused by neoplasms. In at least 24 of the 56 (43%) individuals with epilepsy that died from a malignant neoplasm (except brain tumor), the onset of malignancy occurred prior to the first seizure.
Significantly fewer patients with epilepsy died from heart disease than in the general population (Table 1 ; p < 0.001). Of the patients with epilepsy that died from cardiac disease, 97.4% were >60 years of age (Table 2 ). In at least 28/39 (71.8%) of the epilepsy patients, the onset of cardiac disease or cerebrovascular disease occurred before the onset of epilepsy. Cerebrovascular disease caused a similar proportion of deaths in the epilepsy population and the general population (Table 1 ; p = 0.152). Of the 25 patients in the epilepsy population that died from cerebrovascular disease, for 18 (72%) the epilepsy was secondary to cerebrovascular disease, and 19 of these deaths were acute stroke.
All patients with epilepsy that died from pneumonia had severe underlying and/or comorbid predisposing conditions; four were mentally disabled, of whom two had Down's syndrome; two were multimorbid elderly individuals with epilepsy secondary to cerebrovascular disease, and two had neurodegenerative disease.
Of the two deaths from suicide in the epilepsy population, both had experienced significant psychosocial distress before seizure onset.
It was not possible to determine whether or not the five fatal accidents among the patients with epilepsy (Table 1) were caused by seizures. However, there were 12 cases of definite and probable SUDEP, two cases of status epilepticus, and one drowning that was considered to be seizure-related. In addition, in three of the seven possible SUDEP cases, aspiration of gastric contents was suspected, 7 suggesting that the deaths of these patients were seizurerelated. When these cases of aspiration of gastric contents were also included, the proportion of deaths directly related to seizures in this population of epilepsy patients was at least 6.8% (18/266). Furthermore, if the remaining four possible cases of SUDEP and the five deaths from accidents were also assumed to be seizurerelated, then the proportion of seizure-related deaths could be as high as 10.2% (27/266).
If seizure-related deaths in the epilepsy population were excluded from the category ''other'', then the proportion of deaths in this category did not differ significantly in the epilepsy population from in the general population (Table 1) . Brain tumors  6  4  10  9  46  20  55  50  6  12  218  Pneumonia  2  4  0  0  13  5  156  117  397  737  1431  Suicide  5  3  39  12  24  27  12  8  0  0  130  Accients  78  18  181  42  169  48  154  96  171  295  1252  Other  162  136  287  94  507  216  1530  1165  1470  2429  7996   Sum  277  189  627  250  1765  1102  6421  4486  5574  8641  29,332 F, females; M, males. a Numbers of deaths within each category of age and gender. Of those patients registered with a diagnosis of epilepsy during the ten-year period, 2480 were alive at the end of the period. The distributions of age and gender in the population with epilepsy and in the general population are shown in Table 3 .
Discussion
In this study, the COD in patients with epilepsy and in the general population in the same catchment area have been compared, and our findings add important knowledge on the causes of mortality in people with epilepsy. The distribution of the COD were generally similar to previously published findings 6,9-14 (Table 4) , and, except from a lower proportion of deaths from cardiac disease in the epilepsy patients compared with the general population, no significant differences of proportionate mortality between the two populations were identified. However, the majority of epilepsy patients that died from cardiac or cerebrovascular disease had onset of vascular disease prior to the onset of epilepsy and, similarly, a significant proportion (43%) of those that died from neoplasms had onset of malignancy before seizure onset. This chronological relationship has, to our knowledge, not been previously shown in a clinical study. Our results may suggest that comorbid conditions that are not caused by epilepsy per se or its treatment can explain the previously documented excess mortality in epilepsy.
In a recent population based study 2 from the UK, the overall standardized mortality ratio (SMR) for individuals with definite seizures was 2.6. Our study design does not allow calculation of the SMR, but our objective was to elucidate those conditions that may contribute to the increased mortality and assess their relative significance. This is important as the high mortality could be due to: (a) brain diseases causing both epilepsy and early death; (b) direct epilepsy-related deaths; and (c) indirect effects due to the epilepsy itself or to the use of antiepileptic drugs (AEDs). In addition, comorbid conditions may play a role because a number of comorbidities, including stroke, 15 are more prevalent in epilepsy patients than in the general population. Brain diseases that can cause both epilepsy and premature death include primary brain tumors and cerebrovascular disease. In our study, mortality due to brain tumors was, as expected, considerably higher in the epilepsy patients than in the general population. Previous studies have reported a significantly increased mortality in epilepsy from cerebrovascular disease 2,3 and in our study the proportion of deaths due to cerebrovascular disease was also slightly, but not significantly, elevated compared with the general population. However, we found that epilepsy was secondary to cerebral stroke in 18 of the 25 patients that died from cerebrovascular disease, indicating that the epilepsy could not have had a causal association with the first stroke in these cases.
Although a previous study 16 has documented that the risk of a first stroke in patients with seizure onset at or after the age of 60 was significantly higher than in controls, that study did not consider the presence of diabetes, hypertension, hypercholesterolemia and other risk factors for stroke. Thus it is difficult to reach a firm conclusion from that data that the increased risk of stroke in the epilepsy population was due to the epilepsy itself. Similarly, another important finding in our study was that in at least 72% of those who died from cardiac disease, the onset of vascular disease occurred prior to the onset epilepsy. Again, this indicates that there was no causal relationship between epilepsy and the onset of vascular disease in these patients. Some previous studies of cause-specific mortality in epilepsy have indicated an increased mortality from cardiac disease 2, 3, 6 and treatment with old-generation AEDs has been linked to unfavorable changes in blood lipids and other vascular risk factors. 17, 18 However, a study on risk factors for coronary heart disease in males between 30 and 50 years of age and suffering from chronic epilepsy concluded that there was no significant difference in comparison with healthy controls. 19 Additionally, the elevated death rate from cardiac disease in epilepsy patients has been found to occur only in patients <65 years of age. 3, 11 Interestingly, in our study only one of the deaths from cardiac disease occurred in a patient <60 years of age, and three were <65 years old. One possible explanation for our finding may be that patients with epilepsy receive a more thorough medical follow-up than the general population, and this includes a focus on risk factors for cardiovascular disease. In our opinion, neither the results from our study nor the previous literature contains convincing evidence that epilepsy per se or its treatment increases the risk of death from vascular disease. An SMR of 2.6 from malignant neoplasms, excluding brain tumors, was found in patients with definite epilepsy in the UKbased study after a total follow-up up to 25 years. 2 A previous study 12 from the same cohort with a median follow up of 6.9 years reported an SMR of 3.4 for the same COD. However, in our study, when deaths from brain tumors were excluded, the proportion due to neoplasms was about the same in the population with epilepsy as in the general population, and for over 40% of those with epilepsy that died from a malignant neoplasm (except brain tumor), the onset of malignancy occurred prior to the first seizure. Thus, it seems unlikely that epilepsy per se or its treatment has a significant causal effect regarding mortality from neoplasms.
In our study, all those epilepsy patients that died from pneumonia had severe underlying or comorbid conditions. Seizure-related aspiration has previously been suggested as a possible explanation for the increased mortality from pneumonia in people with epilepsy, but this does not explain why this occurs even in seizure-free patients. 2 Our findings suggest that comorbid or underlying conditions may be at least contributory. The use of AEDs has been associated with an increased risk of suicidality. 20, 21 However, the anticipated class effect of AEDs increasing the risk of suicidality has been questioned, 20 as well as the aetiologic role of epilepsy as responsible for the increased risk of suicide. 21 Both suicide cases in our study had experienced significant psychosocial distress prior to the onset of seizures and one of the two was not treated with an AED. Thus, our study provides no support for the concept that AED use increases the risk of suicide. At least 6.8%, and perhaps as high as over 10%, of the deaths among the epilepsy population in our study were directly related to seizures. Other than these, the deaths were caused by comorbid conditions, of which a significant proportion was present prior to the onset of epilepsy. This suggests that comorbid conditions unrelated to epilepsy may explain the previously reported significantly increased SMR in the epilepsy population. [1] [2] [3] This suggestion concurs with previous findings of higher mortality in symptomatic epilepsy than in cryptogenic or idiopathic epilepsy. 1, 2, 12, 22 During the 10-year period of the study, the epilepsy patients in the catchment area of Stavanger University Hospital received care from hospital specialists in cooperation with general practitioners. Therefore, although the present study is hospital-based, the results from a similar population based study in the same catchment area would probably have produced similar results. The distribution of age and gender in the epilepsy population at risk was also fairly similar to that of the general population.
One limitation of this study is the retrospective design and the lack of classification of the epilepsy syndromes of the cohort. This means that the possibility that some of the epilepsy diagnoses may have been incorrect cannot be excluded. Furthermore, as our cohort consisted of both prevalent and incident cases this may have affected the results, as mortality in epilepsy is higher during the first years after seizure onset.
3,4 As we have not estimated the SMR of the epilepsy population in this study, our results should not be interpreted as documenting a reduced risk of dying from cardiac disease in people with epilepsy, nor as a demonstration of an equal risk of dying from the other COD that were investigated.
Conclusions
Our findings suggest that comorbid conditions not caused by epilepsy or its treatment are more important in increasing the mortality in the epilepsy population than previously realized. Apart from those deaths that were directly related to seizures, neither our results nor the results from previous studies provide convincing evidence that the diagnosis of epilepsy per se imposes a significantly increased risk of premature death.
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